Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 257807, 6 pages
http://dx.doi.org/10.1155/2014/257807
Research Article

Acceptability of Human Papillomavirus Vaccine: A Survey among Master of Business Administration Students in KwaZulu-Natal, South Africa

1Graduate School of Business and Leadership, University of KwaZulu-Natal, Durban 4000, South Africa
2Medical Sociology and Health Policy, University of Antwerp, Antwerp 2610, Belgium

Received 8 April 2014; Accepted 8 July 2014; Published 5 August 2014

Academic Editor: Massimo Origoni

Copyright © 2014 Muhammad Ehsanul Hoque and Guido Van Hal. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. HPV Information Centre (WHO/ICO Informa tion Centre on HPV and Cervical Cancer), “Human Papillomavirus and Related Cancers in South Africa. Summary Report 2010,” 2010, http://www.who.int/ hpvcentre.
  3. N. Mqoqi, P. Kellett, F. Sitas, and M. Jula, Incidence of Histologically Diagnosed Cancer in South Africa, 1998-1999, National Cancer Registry of South Africa, National Health Laboratory Service, Johannesburg, South Africa, 2004.
  4. Cancer Association of South Africa (CANSA), Summary statistics of cancer diagnosed histologically in 2006, http://www.cansa.org.za/files/2014/06/NCR_2006_TABLES_FINAL.pdf.
  5. M. T. Mamahlodi, L. R. Kuonza, and S. Candy, “Cervical cancer screening programme in Limpopo province: January 2007 to December 2010,” Southern African Journal of Gynaecological Oncology, vol. 5, no. 1, pp. 4–10, 2013. View at Google Scholar
  6. L. C. Snyman and U. Herbst, “Reasons why unscreened patients with cervical cancer present with advanced stage disease,” Southern African Journal of Gynaecological Oncology, vol. 5, no. 1, pp. 16–20, 2013. View at Google Scholar
  7. P. Boyle and B. Levin, Eds., World Cancer Report 2008, World Health Organization, International Agency for Research on Cancer, Lyon, France, 2008, http://www.iarc.fr/en/publications/pdfs-online/wcr/2008/index.php.
  8. N. Muñoz and A. C. Jacquard, “What should be known for the introduction of an HPV vaccine?” Presse Medicale, vol. 37, no. 10, pp. 1377–1390, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. J. H. Hershey and L. F. Velez, “Public health issues related to HPV vaccination,” Journal of Public Health Management and Practice, vol. 15, no. 5, pp. 384–392, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. T. H. Laz, M. Rahman, and A. B. Berenson, “An update on human papillomavirus vaccine uptake among 11–17 year old girls in the United States: National Health Interview Survey, 2010,” Vaccine, vol. 30, no. 24, pp. 3534–3540, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Limia and I. Pachón, “Coverage of human papillomavirus vaccination during the first year of its introduction in Spain,” Eurosurveillance, vol. 16, no. 21, 2011. View at Google Scholar · View at Scopus
  12. Information Services and NHS National Services Scotland, Human Papilloma Virus (HPV) Immunisation uptake Rates. Year 3 of the HPV Immunisation Programme (2010/11), 2011.
  13. “Annual HPV vaccine coverage in England in 2009/2010,” Department of Health, 2011.
  14. M. Rondy, A. van Lier, J. van de Kassteele, L. Rust, and H. de Melker, “Determinants for HPV vaccine uptake in the Netherlands: a multilevel study,” Vaccine, vol. 28, no. 9, pp. 2070–2075, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Binagwaho, C. M. Wagner, M. Gatera, C. Karema, C. T. Nutt, and F. Ngabo, “Achieving high coverage in Rwanda's national human papillomavirus vaccination programme,” Bulletin of the World Health Organization, vol. 90, no. 8, pp. 623–628, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Basu and S. Mittal, “Acceptability of human papillomavirus vaccine among the urban, affluent and educated parents of young girls residing in Kolkata, Eastern India,” Journal of Obstetrics and Gynaecology Research, vol. 37, no. 5, pp. 393–401, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. T. DiAngi, C. A. Panozzo, D. Ramogola-Masire, A. P. Steenhoff, and N. T. Brewer, “A cross-sectional study of hpv vaccine acceptability in gaborone, botswana,” PLoS ONE, vol. 6, no. 10, Article ID e25481, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. M. A. Coleman, J. Levison, and H. Sangi-Haghpeykar, “HPV vaccine acceptability in Ghana, West Africa,” Vaccine, vol. 29, no. 23, pp. 3945–3950, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. Health System Trust, The District Health Barometer 2008/2009. Part A. Indicator comparison by districts. Output indicators: immunization, 2010, http://www.hst.org.za/sites/default/files/dhb0809_31.pdf.
  20. J. Corrigall, D. Coetzee, and N. Cameron, “Is the Western Cape at risk of an outbreak of preventable childhood diseases? Lessons from an evaluation of routine immunisation coverage,” South African Medical Journal, vol. 98, no. 1, pp. 41–45, 2008. View at Google Scholar · View at Scopus
  21. M. E. Hoque, S. Ghuman, and G. van Hal, “Human Papillomavirus vaccination acceptability among female university students in South Africa,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 8, pp. 4865–4869, 2013. View at Google Scholar
  22. D. N. Poole, J. K. Tracy, L. Levitz et al., “A cross-sectional study to assess HPV knowledge and HPV vaccine acceptability in Mali,” PLoS ONE, vol. 8, no. 2, Article ID e56402, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. K. A. Ports, D. M. Reddy, and A. Rameshbabu, “Barriers and facilitators to HPV vaccination: perspectives from Malawian women,” Women and Health, vol. 53, no. 6, pp. 630–645, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Remes, V. Selestine, J. Changalucha et al., “A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania,” Vaccine, vol. 30, no. 36, pp. 5363–5367, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Trim, N. Nagji, L. Elit, and K. Roy, “Parental knowledge, attitudes, and behaviours towards human papillomavirus vaccination for their children: a systematic review from 2001 to 201,” Obstetrics and Gynecology International, vol. 2012, Article ID 921236, 12 pages, 2012. View at Publisher · View at Google Scholar
  26. J. Harries, J. Moodley, M. A. Barone, S. Mall, and E. Sinanovic, “Preparing for HPV vaccination in South Africa: key challenges and opinions,” Vaccine, vol. 27, no. 1, pp. 38–44, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. S. T. Vadaparampil, J. A. Kahn, D. Salmon et al., “Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited,” Vaccine, vol. 29, no. 47, pp. 8634–8641, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. M. F. Daley, N. Liddon, L. A. Crane et al., “A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination,” Pediatrics, vol. 118, no. 6, pp. 2280–2289, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. P. J. Smith, S. G. Humiston, E. K. Marcuse et al., “Parental delay or refusal of vaccine doses, childhood vaccination coverage at 24 months of age, and the Health Belief Model,” Public Health Reports, vol. 126, no. 2, pp. 135–146, 2011. View at Google Scholar · View at Scopus